Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 346 | 3 | 376 | +33 |
| Shares | 88.9M | 131.0K | 96.6M | +7.85M (+8.8%) |
| Value | $6.15B | $9.07M | $6.62B | +$477.6M (+7.8%) |
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (76)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (43)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (3)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 124,596 | $8.62M |
| Handelsinvest Investeringsforvaltning | 3,217 | $223.0K |
| Cipher Capital LP | 3,179 | $220.0K |